271 related articles for article (PubMed ID: 32400836)
1. Coaxial mussel-inspired biofibers: making of a robust and efficacious depot for cancer drug delivery.
Talebian S; Shim IK; Kim SC; Spinks GM; Vine KL; Foroughi J
J Mater Chem B; 2020 Jun; 8(23):5064-5079. PubMed ID: 32400836
[TBL] [Abstract][Full Text] [Related]
2. 3D-Printed Coaxial Hydrogel Patches with Mussel-Inspired Elements for Prolonged Release of Gemcitabine.
Talebian S; Shim IK; Foroughi J; Orive G; Vine KL; Kim SC; Wallace GG
Polymers (Basel); 2021 Dec; 13(24):. PubMed ID: 34960917
[TBL] [Abstract][Full Text] [Related]
3. The conjugates of forky peptides and nonsteroidal anti-inflammatory drugs (NSAID) self-assemble into supramolecular hydrogels for prostate cancer-specific drug delivery.
Tao M; He S; Liu J; Li H; Mei L; Wu C; Xu K; Zhong W
J Mater Chem B; 2019 Jan; 7(3):469-476. PubMed ID: 32254734
[TBL] [Abstract][Full Text] [Related]
4. Programming Drug Delivery Kinetics for Active Burst Release with DNA Toehold Switches.
Xiao M; Lai W; Wang F; Li L; Fan C; Pei H
J Am Chem Soc; 2019 Dec; 141(51):20354-20364. PubMed ID: 31790242
[TBL] [Abstract][Full Text] [Related]
5. Anti-tumor efficacy of folate modified PLGA-based nanoparticles for the co-delivery of drugs in ovarian cancer.
Li S; Li X; Ding J; Han L; Guo X
Drug Des Devel Ther; 2019; 13():1271-1280. PubMed ID: 31114163
[No Abstract] [Full Text] [Related]
6. Fabrication of an injectable hydrogel with inherent photothermal effects from tannic acid for synergistic photothermal-chemotherapy.
Zhu X; Guan B; Sun Z; Tian X; Li X
J Mater Chem B; 2021 Aug; 9(30):6084-6091. PubMed ID: 34286812
[TBL] [Abstract][Full Text] [Related]
7. Injectable and biocompatible alginate-derived porous hydrogels cross-linked by IEDDA click chemistry for reduction-responsive drug release application.
Vu TT; Gulfam M; Jo SH; Park SH; Lim KT
Carbohydr Polym; 2022 Feb; 278():118964. PubMed ID: 34973779
[TBL] [Abstract][Full Text] [Related]
8. Modified gaphene oxide (GO) particles in peptide hydrogels: a hybrid system enabling scheduled delivery of synergistic combinations of chemotherapeutics.
Schneible JD; Shi K; Young AT; Ramesh S; He N; Dowdey CE; Dubnansky JM; Lilova RL; Gao W; Santiso E; Daniele M; Menegatti S
J Mater Chem B; 2020 May; 8(17):3852-3868. PubMed ID: 32219269
[TBL] [Abstract][Full Text] [Related]
9. Biodegradable chitin nanofiber-alginate dialdehyde hydrogel: An injectable, self-healing scaffold for anti-tumor drug delivery.
Lin X; Long H; Zhong Z; Ye Q; Duan B
Int J Biol Macromol; 2024 Jun; 270(Pt 2):132187. PubMed ID: 38723827
[TBL] [Abstract][Full Text] [Related]
10. 3D printed core-shell hydrogel fiber scaffolds with NIR-triggered drug release for localized therapy of breast cancer.
Wei X; Liu C; Wang Z; Luo Y
Int J Pharm; 2020 Apr; 580():119219. PubMed ID: 32165221
[TBL] [Abstract][Full Text] [Related]
11. Micellar nanoparticles loaded with gemcitabine and doxorubicin showed synergistic effect.
Liu D; Chen Y; Feng X; Deng M; Xie G; Wang J; Zhang L; Liu Q; Yuan P
Colloids Surf B Biointerfaces; 2014 Jan; 113():158-68. PubMed ID: 24077114
[TBL] [Abstract][Full Text] [Related]
12. Near-Infrared Light-Triggered Drug Release from Ultraviolet- and Redox-Responsive Polymersome Encapsulated with Core-Shell Upconversion Nanoparticles for Cancer Therapy.
Tsai MF; Lo YL; Soorni Y; Su CH; Sivasoorian SS; Yang JY; Wang LF
ACS Appl Bio Mater; 2021 Apr; 4(4):3264-3275. PubMed ID: 35014413
[TBL] [Abstract][Full Text] [Related]
13. Enzyme-responsive peptide dendrimer-gemcitabine conjugate as a controlled-release drug delivery vehicle with enhanced antitumor efficacy.
Zhang C; Pan D; Li J; Hu J; Bains A; Guys N; Zhu H; Li X; Luo K; Gong Q; Gu Z
Acta Biomater; 2017 Jun; 55():153-162. PubMed ID: 28259838
[TBL] [Abstract][Full Text] [Related]
14. Fabrication of dopamine conjugated with protein @metal organic framework for targeted drug delivery: A biocompatible pH-Responsive nanocarrier for gemcitabine release on MCF‑7 human breast cancer cells.
Abd Al-Jabbar S; Atiroğlu V; Hameed RM; Guney Eskiler G; Atiroğlu A; Deveci Ozkan A; Özacar M
Bioorg Chem; 2022 Jan; 118():105467. PubMed ID: 34781115
[TBL] [Abstract][Full Text] [Related]
15. Microfluidics-Assisted Surface Trifunctionalization of a Zeolitic Imidazolate Framework Nanocarrier for Targeted and Controllable Multitherapies of Tumors.
Shen J; Ma M; Zhang H; Yu H; Xue F; Hao N; Chen H
ACS Appl Mater Interfaces; 2020 Oct; 12(41):45838-45849. PubMed ID: 32956582
[TBL] [Abstract][Full Text] [Related]
16. Theranostic nanoparticles enabling the release of phosphorylated gemcitabine for advanced pancreatic cancer therapy.
Wang Q; Zhu X; Wu Z; Sun T; Huang W; Wang Z; Ding X; Jiang C; Li F
J Mater Chem B; 2020 Mar; 8(12):2410-2417. PubMed ID: 32100811
[TBL] [Abstract][Full Text] [Related]
17. Multifunctional Ionic Hydrogel-Based Transdermal Delivery of 5-Fluorouracil for the Breast Cancer Treatment.
Pansuriya R; Patel T; Kumar S; Aswal VK; Raje N; Hoskins C; Kailasa SK; Malek NI
ACS Appl Bio Mater; 2024 May; 7(5):3110-3123. PubMed ID: 38620030
[TBL] [Abstract][Full Text] [Related]
18. AS1411 aptamer and folic acid functionalized pH-responsive ATRP fabricated pPEGMA-PCL-pPEGMA polymeric nanoparticles for targeted drug delivery in cancer therapy.
Lale SV; R G A; Aravind A; Kumar DS; Koul V
Biomacromolecules; 2014 May; 15(5):1737-52. PubMed ID: 24689987
[TBL] [Abstract][Full Text] [Related]
19. Thermo-sensitive polypeptide hydrogel for locally sequential delivery of two-pronged antitumor drugs.
Wei L; Chen J; Zhao S; Ding J; Chen X
Acta Biomater; 2017 Aug; 58():44-53. PubMed ID: 28576715
[TBL] [Abstract][Full Text] [Related]
20. Injectable visible light-cured glycol chitosan hydrogels with controlled release of anticancer drugs for local cancer therapy in vivo: a feasible study.
Hyun H; Park MH; Lim W; Kim SY; Jo D; Jung JS; Jo G; Um S; Lee DW; Yang DH
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):874-882. PubMed ID: 29749265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
